Project Grant CLSS00000066522

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

Federal Grant Award Summary The Naloxone Project (TNP) received a $600,000 Project Grant award effective September 1, 2025, through August 31, 2026, from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912). The COLORADO CHANGE (Coalition for Harm Reduction, Access to Naloxone, and Grassroots Rural Engagement) project addresses the opioid overdose crisis in Colorado's rural communities, where opioids were involved in over 62% of the state's 7,022...

The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance awarded a $1,600,000 Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) Project Grant to the Southern Nevada Health District (SNHD) and sub-recipients Las Vegas Metropolitan Police Department (LVMPD) and University of Nevada, Las Vegas (UNLV). The grant will fund a collaborative initiative to address the opioid crisis in Clark County, Nevada through a public health-focused overdose...

Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $453,062 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. The award supports research investigating the control of opioid receptor signaling and pharmacological tolerance through endosomal recycling and retromer complex mechanisms. The project employs proteomic and genomic...

Federal Grant Award Summary Louisiana State University Health Sciences Center New Orleans received a $225,065 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 15, 2025, with a completion date of July 31, 2027. The award supports research on targeting the renin system as a novel therapeutic approach for managing chronic pain and opioid use disorder (OUD). The project leverages the FDA-approved...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded the University of Pittsburgh a $198,164 Project Grant on September 25, 2025, to support basic neuroscience research investigating delta opioid receptor (DOR) regulation in the prefrontal cortex and its relationship to opioid use disorder (OUD) and oxycodone-related behavioral outcomes. The research will be conducted in Pittsburgh, Pennsylvania,...

This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...

This $424,545 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a national survey on naloxone use and access. The survey, conducted by the RAND Corporation, will provide critical, timely evidence on the state of naloxone carrying and purchasing behavior in the U.S., including the impact of recently approved over-the-counter naloxone products. The project will monitor knowledge, barriers, and willingness-to-pay...

The City of Longview was awarded a $953,468 Project Grant from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant will fund an opioid use intervention strategy and public education campaign in the Longview, Texas area. Key components include: Implementing an alternative 911 response model by adding a Community Health Paramedic to provide immediate medical assistance, screenings,...

Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $709,085 to the University of Colorado-Denver for an implementation research trial commencing April 1, 2026, and concluding January 31, 2031. This project delivers implementation facilitation services and clinical intervention support designed to expand in-hospital opioid treatment program (OTP) intakes for hospitalized patients with opioid...